650 JOURNAL OF COSMETIC SCIENCE
innervated and vascularized, playing vital roles in immune response and neuroendocrine
function.30 Thus, the similarities and the interconnectedness of their respective microbiomes
highlight the importance of maintaining balance in both for overall systemic health.30
Disruptions in one organ can lead to dysbiosis in the other, as emerging research illustrates
the immunomodulating potential of microbiomes on distant organs.3
The application of therapeutic and nutricosmetic interventions based on the gut-skin axis
suggests that similar approaches might be possible for the skin-gut axis in the future, raising
intriguing possibilities for researchers to design and create novel cosmetic and therapeutic
products. For example, the aforementioned research by Dokoshi et al. (2024), that shows
how cutaneous inflammation can alter the gut microbiome, may guide the development of
cosmetic products that enhance dermal stability and prevent disturbances in both the skin
and gut microbiome.6 Formulating products to reduce skin inflammation could, in turn,
help avert gut microbiome dysbiosis, potentially through topical synbiotics or LBPs.
Transdermal therapeutics exemplify how skin-targeted treatments can achieve systemic
effects.172 Although the concept of transdermal drug delivery dates back to 3000 BC with
use in ancient Egyptian and Babylonian medicine, it only became widespread in the latter
part of the 20th century. This shift occurred with advancements in delivery technologies
that allowed for the precise and consistent administration of medication through the
skin.173 Notable and relevant examples include the daily application of patented vitamin
D3 patches, which effectively increase serum 25-hydroxyvitamin D (25(OH)D) levels, and
studies involving biomimetic nanovesicles (tiny vesicle-like structures designed to mimic
biological membranes) loaded with folic acid and iron incorporated into polyacrylate-based
transdermal patches.172,174 These nanovesicles demonstrated the ability to fluidize skin
lipids and penetrate deeper layers, thereby enhancing nutrient absorption.174
Furthermore, the emerging field of neurocosmetics, which harnesses the skin-brain axis to
influence interactions between the skin and the nervous system through skincare products,
offers a potential framework for future applications involving the skin-gut axis.175 This field
encompasses a range of functional ingredients and commercial products that are specifically
designed to be applied to the skin and subsequently operate at a neurological level. These
products affect the cutaneous nervous system and modulate the skin’s neuromediators
through various mechanisms of action, and the skin-gut axis may be affected similarly.175
While extensive research is essential to fully elucidate the bidirectional nature of the gut-
skin/skin-gut axis, the expanding body of literature on this communication pathway is
both exciting and promising.6,166,168,170 This ongoing investigation into the gut-skin axis
has highlighted its significant role in various skin conditions and overall skin health,
underscoring one aspect of this complex relationship. Moreover, understanding the reverse
skin-gut axis opens new avenues for developing innovative treatments and strategies. By
leveraging the accessibility of the skin—the body’s largest organ—and its interconnectedness
with other organs, researchers can explore both therapeutic and cosmetic approaches to
achieve systemic benefits.
REFERENCES
(1) Aggarwal N, Kitano S, Puah GRY, Kittelmann S, Hwang IY, Chang MW. Microbiome and human
health: current understanding, engineering, and enabling technologies. Chem Rev. 2023 123(1):31–72.
doi:10.1021/acs.chemrev.2c00431
651 Bidirectional Gut-Skin Axis
(2) Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011 9(4):244–253. doi:10.1038/
nrmicro2537
(3) De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: current
knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms.
February 2021 9(2). doi:10.3390/microorganisms9020353
(4) Mahmud MR, Akter S, Tamanna SK, et al. Impact of gut microbiome on skin health: gut-skin axis
observed through the lenses of therapeutics and skin diseases. Gut Microbes. July 2022 14(1):2096995. doi
:10.1080/19490976.2022.2096995
(5) den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-
chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res.
2013 54(9):2325–2340. doi:10.1194/jlr.R036012
(6) Dokoshi T, Chen Y, Cavagnero KJ, et al. Dermal injury drives a skin to gut axis that disrupts the
intestinal microbiome and intestinal immune homeostasis in mice. Nat Commun. April 2024 15(1):3009.
doi:10.1038/​s41467-024-47072-3
(7) Hiergeist A, Gläsner J, Reischl U, Gessner A. Analyses of intestinal microbiota: culture versus
sequencing. ILAR J. 2015 56(2):228–240. doi:10.1093/ilar/ilv017
(8) Aguiar-Pulido V, Huang W, Suarez-Ulloa V, Cickovski T, Mathee K, Narasimhan G. Metagenomics,
metatranscriptomics, and metabolomics approaches for microbiome analysis. Evol Bioinform Online.
2016 12(suppl 1):5–16. doi:10.4137/EBO.S36436
(9) Handelsman J, Rondon MR, Brady SF, Clardy J, Goodman RM. Molecular biological access to the
chemistry of unknown soil microbes: A new frontier for natural products. Chem Biol. 1998 5(10):​
R245–R249. doi:10.1016/s1074-5521(98)90108-9
(10) Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012 70(suppl
1):S38–S44. doi:10.1111/j.1753-4887.2012.00493.x
(11) Martín R, Miquel S, Langella P, Bermúdez-Humarán LG. The role of metagenomics in understanding
the human microbiome in health and disease. Virulence. 2014 5(3):413–423. doi:10.4161/viru.27864
(12) Payne M, Azana R, Hoang LMN. Review of 16S and ITS direct sequencing results for clinical specimens
submitted to a reference laboratory. Can J Infect Dis Med Microbiol. 2016 (March 2016) 2016:4210129.
doi:10.1155/2016/4210129
(13) Thomas T, Gilbert J, Meyer F. Metagenomics a guide from sampling to data analysis. Microb Inform
Exp. February 2012 2(1):3. doi:10.1186/2042-5783-2-3
(14) Logsdon GA, Vollger MR, Eichler EE. Long-read human genome sequencing and its applications. Nat
Rev Genet. 2020 21(10):597–614. doi:10.1038/s41576-020-0236-x
(15) Grundy BS, Parikh H, Jacob S, et al. Pathogen detection using metagenomic next-generation sequencing
of plasma samples from patients with sepsis in Uganda. Microbiol Spectr. January 2023 11(1):e0431222.
doi:10.1128/spectrum.04312-22
(16) Pan S, Chen R. Metaproteomic analysis of human gut microbiome in digestive and metabolic diseases.
Adv Clin Chem. 2020 97:1–12. doi:10.1016/bs.acc.2019.12.002
(17) Al-Amrani S, Al-Jabri Z, Al-Zaabi A, Alshekaili J, Al-Khabori M. Proteomics: concepts and applications
in human medicine. World J Biol Chem. 2021 12(5):57–69. doi:10.4331/wjbc.v12.i5.57
(18) Han X, Gross RW. The foundations and development of lipidomics. J Lipid Res. February 2022 63(2):​
100164. doi:10.1016/j.jlr.2021.100164
(19) Chetty A, Blekhman R. Multi-omic approaches for host-microbiome data integration. Gut Microbes.
2024 16(1):2297860. doi:10.1080/19490976.2023.2297860
(20) Bharti R, Grimm DG. Current challenges and best-practice protocols for microbiome analysis. Brief
Bioinform. 2021 22(1):178–193. doi:10.1093/bib/bbz155
(21) Huang H, Ren Z, Gao X, et al. Integrated analysis of microbiome and host transcriptome reveals
correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Genome Med. November 2020 12(1):102. doi:10.1186/s13073-020-00796-5
Previous Page Next Page